Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Research priorities in Maternal, Newborn, & Child Health & Nutrition for India: An Indian Council of Medical Research-INCLEN Initiative.
Arora NK, Swaminathan S, Mohapatra A, Gopalan HS, Katoch VM, Bhan MK, Rasaily R, Shekhar C, Thavaraj V, Roy M, Das MK, Wazny K, Kumar R, Khera A, Bhatla N, Jain V, Laxmaiah A, Nair MKC, Paul VK, Ramachandran P, Ramji S, Vaidya U, Verma IC, Shah D, Bahl R, Qazi S, Rudan I, Black RE; ICMR INCLEN Research Priority Setting Network; National Steering Group; Research Sub-Committee; Nation-wide Network. Arora NK, et al. Indian J Med Res. 2017 May;145(5):611-622. doi: 10.4103/ijmr.IJMR_139_17. Indian J Med Res. 2017. PMID: 28948951 Free PMC article.
Feasibility randomised controlled trial of face-to-face counselling and mobile phone messages compared to usual care for smokeless tobacco cessation in Indian primary care: Project CERTAIN.
Panda R, Omar R, Hunter R, Lahoti S, Prabhu RR, Vickerstaff V, Satapathy DM, Das S, Nazareth I. Panda R, et al. Among authors: satapathy dm. Nicotine Tob Res. 2024 Apr 27:ntae038. doi: 10.1093/ntr/ntae038. Online ahead of print. Nicotine Tob Res. 2024. PMID: 38676604
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.
Raghav S, Ghosh A, Turuk J, Kumar S, Jha A, Madhulika S, Priyadarshini M, Biswas VK, Shyamli PS, Singh B, Singh N, Singh D, Datey A, Avula K, Smita S, Sabat J, Bhattacharya D, Kshatri JS, Vasudevan D, Suryawanshi A, Dash R, Senapati S, Beuria TK, Swain R, Chattopadhyay S, Syed GH, Dixit A, Prasad P; Odisha COVID-19 Study Group; ILS COVID-19 Team; Pati S, Parida A. Raghav S, et al. Front Microbiol. 2020 Nov 23;11:594928. doi: 10.3389/fmicb.2020.594928. eCollection 2020. Front Microbiol. 2020. PMID: 33329480 Free PMC article.
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.
Kshatri JS, Bhattacharya D, Kanungo S, Giri S, Palo SK, Parai D, Turuk J, Mansingh A, Choudhary HR, Pattnaik M, Dash GC, Mohanty P, Mishra N, Satapathy DM, Sahoo SK, Pati S; ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team. Kshatri JS, et al. Among authors: satapathy dm. Sci Rep. 2021 May 18;11(1):10551. doi: 10.1038/s41598-021-89877-y. Sci Rep. 2021. PMID: 34006960 Free PMC article.
Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
Ashwath Narayana DH, Madhusudana SN, Sampath G, Tripathy RM, Sudarshan MK, Gangaboraiah, Ravish HS, Satapathy DM, Gowda G, Holla R, Ashwin BY, Padhi A, Manjula S, Patel PM. Ashwath Narayana DH, et al. Among authors: satapathy dm. Hum Vaccin Immunother. 2014;10(1):120-5. doi: 10.4161/hv.26456. Epub 2013 Sep 12. Hum Vaccin Immunother. 2014. PMID: 24030586 Free PMC article. Clinical Trial.
Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India.
Kanungo S, Giri S, Bhattacharya D, Kshatri JS, Palo SK, Parai D, Turuk J, Praharaj I, Mansingh A, Dash GC, Choudhary HR, Pattnaik M, Barik SR, Mohanta AR, Swain A, Mohapatra I, Sahoo RK, Mishra RP, Patro SK, Satapathy DM, Pati S; ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team. Kanungo S, et al. Among authors: satapathy dm. J Infect Dev Ctries. 2023 Sep 30;17(9):1255-1261. doi: 10.3855/jidc.17237. J Infect Dev Ctries. 2023. PMID: 37824363 Free article.
Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study.
H S R, Khobragade A, Satapathy D, Gupta M, Kumar S, Bhomia V, V R, Desai M, Agrawal AD. H S R, et al. Hum Vaccin Immunother. 2021 Nov 2;17(11):4239-4245. doi: 10.1080/21645515.2021.1957413. Epub 2021 Sep 9. Hum Vaccin Immunother. 2021. PMID: 34499574 Free PMC article. Clinical Trial.
15 results